Literature DB >> 1090756

Escherichia coli capsule bacteriophages. V. Lysozyme 29.

H Eichholtz, E Freund-Mölbert, S Stirm.   

Abstract

In addition to the spike-associated host capsule depolymerase, infection by Escherichia coli capsule bacteriophage no. 29 also induces the synthesis of a large bacteriolytic enzyme which has been purified to homogeneity. On incubation of isolated host murein sacculi with this enzyme, no amino groups but reducing sugar groups were liberated, and muraminitol, but no glucosaminitol, was found in the degraded sacculi after subsequent reduction with NaBH4. The bacteriolytic enzyme is thus another lysozyme (mucopeptide N-acetylmuramylhydrolase; EC 3.2.1.17). Electron optical visualization of negatively stained lysozyme specimens showed oblong particles of roughly 4.5 to 5.5 nm in diameter and 15 to 19 nm in length. Although the material tended to dissociate, a crude estimate of its molecular weight (270,000 plus or minus 30,000) could be obtained from these dimensions, from its sedimentation equilibrium, and from its behavior in gel chromatography. After disintegration of homogeneous lysozyme 29 by heating in solution with sodium dodecyl sulfate and dithiothreitol, polypeptides of one size only (about 46,000 dalton, probably six copies per molecule) were found in sodium dodecyl sulfate-polyacrylamide electrophoresis. The amino acid analysis of the enzyme accounted for more than 90% of its dry weight. One percent or less of the bacteriolytic activity in phage 29 lysates was found to be associated with the intact or disrupted virus particles, and a polypeptide of 46,000 daltons was not detected in the virions. These results strongly suggest that, in contrast to the host capsule depolymerase also induced by the same phage, and in spite of its comparatively large size, "lysozyme 29" does not constitute an integral part also of the homologous bacteriophage particles.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090756      PMCID: PMC354543     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  [COMPARATIVE STUDIES ON PARTICLE-BOUND AND FREE T2 LYSOZYME AND CRYSTALLIZATION OF BOTH ENZYMES].

Authors:  W KATZ
Journal:  Z Naturforsch B       Date:  1964-02       Impact factor: 1.047

2.  EQUILIBRIUM ULTRACENTRIFUGATION OF DILUTE SOLUTIONS.

Authors:  D A YPHANTIS
Journal:  Biochemistry       Date:  1964-03       Impact factor: 3.162

3.  [MUCOPEPTIDE HYDROLASES IN ESCHERICHIA COLI B. I. DEMONSTRATION AND SPECIFICITY].

Authors:  H PELZER
Journal:  Z Naturforsch B       Date:  1963-11       Impact factor: 1.047

4.  Bacterial viruses; with particular reference to adsorption/penetration.

Authors:  W WEIDEL
Journal:  Annu Rev Microbiol       Date:  1958       Impact factor: 15.500

5.  Lysis of gram-negative organisms and the role of versene.

Authors:  R REPASKE
Journal:  Biochim Biophys Acta       Date:  1958-11

6.  An agent derived from B. megaterium phage G which dissolves the bacterial cell wall.

Authors:  J S MURPHY
Journal:  Virology       Date:  1960-06       Impact factor: 3.616

7.  A phage-associated enzyme of Bacillus megaterium which destroys the bacterial cell wall.

Authors:  J S MURPHY
Journal:  Virology       Date:  1957-12       Impact factor: 3.616

8.  Isolation of spike-formed particles from bacteriophage lysates.

Authors:  S Stirm; W Bessler; F Fehmel; E Freund-Mölbert; H Thurow
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

9.  Escherichia coli capsule bacteriophages. II. Morphology.

Authors:  S Stirm; E Freund-Mölbert
Journal:  J Virol       Date:  1971-09       Impact factor: 5.103

10.  OBSERVATIONS ON THE GROUP C STREPTOCOCCAL BACTERIOPHAGE AND LYTIC ENZYME SYSTEM.

Authors:  E N FOX; M K WITTNER
Journal:  J Bacteriol       Date:  1965-02       Impact factor: 3.490

View more
  1 in total

1.  Cell wall lysin as a component of the bacteriophage phi 6 virion.

Authors:  L Mindich; J Lehman
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.